Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.46B |
| 2 |
Apple
AAPL
|
+$931M |
| 3 |
Tesla
TSLA
|
+$793M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$769M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$644M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$703M |
| 2 |
Bank of America
BAC
|
+$690M |
| 3 |
Amazon
AMZN
|
+$678M |
| 4 |
JPMorgan Chase
JPM
|
+$601M |
| 5 |
Meta Platforms (Facebook)
META
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.11% |
| 2 | Technology | 2.38% |
| 3 | Consumer Discretionary | 1.48% |
| 4 | Healthcare | 0.92% |
| 5 | Communication Services | 0.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3876
Lamb Weston
LW
$7.56B
| $3.73M | ﹤0.01% |
47,389
+31,754
| +203% | +$2.31M |
|
3877
Ocular Therapeutix
OCUL
$2.28B
| $3.73M | ﹤0.01% |
179,960
+42,120
| +31% | +$626K |
|
|
EIDX
3878
PUT
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $3.72M | ﹤0.01% |
28,300
-30,700
| -52% | -$2.71M |
|
3879
ProShares UltraPro Russell2000
URTY
$325M
| $3.72M | ﹤0.01% |
47,225
+26,733
| +130% | +$1.54M |
|
3880
PUT
Middleby
MIDD
$5.1B
| $3.71M | ﹤0.01% |
28,800
-12,200
| -30% | -$1.47M |
|
3881
CALL
United Microelectronic
UMC
$49.6B
| $3.71M | ﹤0.01% |
440,300
+382,500
| +662% | +$2.49M |
|
3882
PUT
Trupanion
TRUP
$1.3B
| $3.71M | ﹤0.01% |
31,000
+25,600
| +474% | +$2.42M |
|
3883
PUT
Seres Therapeutics
MCRB
$51.3M
| $3.71M | ﹤0.01% |
7,570
+4,615
| +156% | +$2.7M |
|
|
UNIT
3884
Uniti Group
UNIT
$2.43B
| $3.71M | ﹤0.01% |
315,900
+227,398
| +257% | +$2.37M |
|
|
HEXO
3885
PUT
DELISTED
HEXO Corp. Common Shares
HEXO
| $3.7M | ﹤0.01% |
71,900
+57,827
| +411% | +$2.74M |
|
3886
CF Industries
CF
$19B
| $3.7M | ﹤0.01% |
95,654
-62,448
| -39% | -$2.06M |
|
3887
PUT
Huntington Bancshares
HBAN
$34.2B
| $3.7M | ﹤0.01% |
293,100
+30,900
| +12% | +$351K |
|
|
ALSK
3888
CALL
DELISTED
Alaska Communications Systems
ALSK
| $3.7M | ﹤0.01% |
+1,002,800
| New | +$2.86M |
|
|
PBCT
3889
PUT
DELISTED
People's United Financial Inc
PBCT
| $3.7M | ﹤0.01% |
286,000
-76,700
| -21% | -$922K |
|
3890
PUT
Ingredion
INGR
$6.6B
| $3.7M | ﹤0.01% |
47,000
+5,800
| +14% | +$447K |
|
|
TWO
3891
CALL
DELISTED
Two Harbors Investment
TWO
| $3.7M | ﹤0.01% |
145,100
+49,650
| +52% | +$1.18M |
|
|
USCR
3892
CALL
DELISTED
U S Concrete, Inc.
USCR
| $3.69M | ﹤0.01% |
92,400
+31,400
| +51% | +$1.12M |
|
3893
CALL
Entegris
ENTG
$20.6B
| $3.69M | ﹤0.01% |
38,400
+3,100
| +9% | +$271K |
|
3894
CALL
Maravai LifeSciences
MRVI
$1.14B
| $3.69M | ﹤0.01% |
+131,500
| New | +$3.66M |
|
|
GLUU
3895
PUT
DELISTED
Glu Mobile Inc.
GLUU
| $3.69M | ﹤0.01% |
409,300
+110,600
| +37% | +$953K |
|
3896
CALL
Phreesia
PHR
$751M
| $3.68M | ﹤0.01% |
+67,900
| New | +$2.91M |
|
3897
PUT
Sunoco
SUN
$14.1B
| $3.68M | ﹤0.01% |
+127,900
| New | +$3.47M |
|
3898
PUT
Direxion Daily Retail Bull 3X ETF
RETL
$25.7M
| $3.68M | ﹤0.01% |
202,500
+175,000
| +636% | +$2.31M |
|
|
KRTX
3899
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $3.68M | ﹤0.01% |
36,183
+15,923
| +79% | +$1.48M |
|
3900
Dow Inc
DOW
$22B
| $3.67M | ﹤0.01% |
66,222
+14,796
| +29% | +$764K |
|
Similar funds
Jeff Yass's Q4 2020 Portfolio in Review
As of Q4 2020, Jeff Yass held 12,204 positions worth $612B, up 17% from $522B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jeff Yass's Q4 2020 filing shows 1,722 new, 4,580 increased, 4,534 reduced and 1,264 closed positions. Its largest new stake was International Flavors & Fragrances: 726,729 shares worth $79.1M. The largest sale was Citigroup, an estimated $703M.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2020 buy was International Flavors & Fragrances: 726,729 shares worth $79.1M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $1.46B increase.
- Jeff Yass's biggest Q4 2020 reduction was Citigroup, cutting an estimated $703M.
- Jeff Yass fully exited Vanguard Total International Bond ETF in Q4 2020, selling an estimated $146M.
- Jeff Yass's ten largest holdings make up 32% of its $612B portfolio in Q4 2020.
- Jeff Yass opened 1,722 new positions and closed 1,264 in Q4 2020.
- Jeff Yass's portfolio value rose 17% quarter-over-quarter to $612B.
Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.